Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 12 (HMGB1P12) is classified as a pseudogene that shares sequence homology with the high-mobility group box (HMGB) family of proteins, particularly with HMGB1, but it is not known to encode a functional protein or participate in physiological processes[3][1]. Pseudogenes like HMGB1P12 generally arise from gene duplication or retrotransposition events and lack the regulatory elements or sequences required for normal gene expression[3]. There are no reports in the scientific literature, or in databases such as GeneCards or Merck/Sigma-Aldrich, of HMGB1P12 functioning as a receptor, enzyme, transporter, transcription factor, or other therapeutic target[3][1]. This entry should not be confused with the functional High mobility group box 1 (HMGB1) protein, which is widely studied as a non-histone chromatin protein implicated in DNA binding, gene regulation, and as a therapeutic target in inflammation, cancer, and immunity[5][6][2]. HMGB1P12 does not have these functional features and is not a valid therapeutic target[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 12 (HMGB1P12).